| 臺大學術典藏 |
2021-07-15T05:31:49Z |
Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC[sbnd]COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study
|
SZU-MIN HSIEH; Liu, Wang Da; Huang, Yu Shan; Lin, Yi Jiun; Hsieh, Erh Fang; Lian, Wei Cheng; Chen, Charles; Janssen, Robert; Shih, Shin Ru; Huang, Chung Guei; Tai, I. Chen; SHAN-CHWEN CHANG |
| 臺大學術典藏 |
2021-08-20T07:38:57Z |
Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC[sbnd]COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study
|
SZU-MIN HSIEH; Liu W.-D.; Huang Y.-S.; Lin Y.-J.; Hsieh E.-F.; Lian W.-C.; Chen C.; Janssen R.; Shih S.-R.; Huang C.-G.; Tai I.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:28Z |
Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC[sbnd]COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study
|
Hsieh S.-M.; Liu W.-D.; YU-SHAN HUANG; Lin Y.-J.; Hsieh E.-F.; Lian W.-C.; Chen C.; Janssen R.; Shih S.-R.; Huang C.-G.; Tai I.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-12-02T05:41:26Z |
Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC[sbnd]COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study
|
Hsieh S.-M.; WANG-DA LIU; Huang Y.-S.; Lin Y.-J.; Hsieh E.-F.; Lian W.-C.; Chen C.; Janssen R.; Shih S.-R.; Huang C.-G.; Tai I.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-20T04:24:49Z |
Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC[sbnd]COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study
|
Hsieh S.-M.; Liu W.-D.; Huang Y.-S.; Lin Y.-J.; Hsieh E.-F.; Lian W.-C.; Chen C.; Janssen R.; Shih S.-R.; Huang C.-G.; Tai I.-C.; SHAN-CHWEN CHANG |
| 臺大學術典藏 |
2018-09-10T09:13:16Z |
Safety and immunogenicity of a split-virion AS03 A-adjuvanted A/Indonesia/05/2005 (H5N1) vaccine in Taiwanese adults
|
Yang, Pan-Chyr;Yu, Chong-Jen;Chang, Shan-Chwen;Hsieh, Szu-Min;Drame, Mamadou;Walravens, Karl;Roman, Francois;Gillard, Paul; Yang, P.-C. and Yu, C.-J. and Chang, S.-C. and Hsieh, S.-M. and Drame, M. and Walravens, K. and Roman, F. and Gillard, P.; 張上淳 ;楊泮池 ;余忠仁 ;謝思民; Yang, Pan-Chyr; Chong-Jen Yu; Yu, Chong-Jen; SZU-MIN HSIEH; SHAN-CHWEN CHANG; Chang, Shan-Chwen; Hsieh, Szu-Min; Drame, Mamadou; Walravens, Karl; Roman, Francois; Gillard, Paul |
| 臺大學術典藏 |
2020-12-02T02:34:00Z |
Safety and immunogenicity of a split-virion AS03 A-adjuvanted A/Indonesia/05/2005 (H5N1) vaccine in Taiwanese adults
|
PAN-CHYR YANG; Yu C.-J.; Chang S.-C.; Hsieh S.-M.; Drame M.; Walravens K.; Roman F.; Gillard P. |
| 臺大學術典藏 |
2020-12-29T06:37:40Z |
Safety and immunogenicity of a split-virion AS03 A-adjuvanted A/Indonesia/05/2005 (H5N1) vaccine in Taiwanese adults
|
Drame M.; Walravens K.; SZU-MIN HSIEH; Chang S.-C.; Yu C.-J.; Yang P.-C.; Roman F.; Gillard P. |
| 臺大學術典藏 |
2022-06-27T07:02:07Z |
Safety and immunogenicity of a split-virion AS03 A-adjuvanted A/Indonesia/05/2005 (H5N1) vaccine in Taiwanese adults
|
Yang P.-C.; CHONG-JEN YU; Chang S.-C.; Hsieh S.-M.; Drame M.; Walravens K.; Roman F.; Gillard P. |
| 國立臺灣大學 |
2012 |
Safety and immunogenicity of a split-virion AS03(A)-adjuvanted A/Indonesia/05/2005 (H5N1) vaccine in Taiwanese adults
|
Yang, Pan-Chyr; Yu, Chong-Jen; Chang, Shan-Chwen; Hsieh, Szu-Min; Drame, Mamadou; Walravens, Karl; Roman, Francois; Gillard, Paul; 張上淳; 楊泮池; 余忠仁; 謝思民 |
